Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4535)
All Articles published online
|
May 7, 2009 (publication date) through Oct 31, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Renga B, Mencarelli A, Migliorati M, Distrutti E, Fiorucci S. Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation. World J Gastroenterol 2009; 15(17): 2097-2108 [PMID: 19418582 DOI: 10.3748/wjg.15.2097] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i17/2097.htm |
| Number | Citing Articles |
| 1 |
Núria Roglans, Elena Fauste, Roger Bentanachs, Ana M. Velázquez, Madelin Pérez-Armas, Cristina Donis, María I. Panadero, Marta Alegret, Paola Otero, Carlos Bocos, Juan C. Laguna. Bempedoic Acid Restores Liver H2S Production in a Female Sprague-Dawley Rat Dietary Model of Non-Alcoholic Fatty Liver. International Journal of Molecular Sciences 2022; 24(1): 473 doi: 10.3390/ijms24010473
|
| 2 |
Eleonora Distrutti, Luca Santucci, Sabrina Cipriani, Barbara Renga, Elisabetta Schiaroli, Patrizia Ricci, Annibale Donini, Stefano Fiorucci. Bile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa. Journal of Gastroenterology 2015; 50(7): 707 doi: 10.1007/s00535-015-1041-8
|
| 3 |
Romain Vuillefroy de Silly, Flora Coulon, Nicolas Poirier, Vojislav Jovanovic, Sophie Brouard, Véronique Ferchaud-Roucher, Gilles Blancho, Bernard Vanhove. Transplant tolerance is associated with reduced expression of cystathionine-γ-lyase that controls IL-12 production by dendritic cells and TH-1 immune responses. Blood 2012; 119(11): 2633 doi: 10.1182/blood-2011-04-350546
|
| 4 |
Nikolay Ishkitiev, Bogdan Calenic, Izumi Aoyama, Hisataka Ii, Ken Yaegaki, Toshio Imai. Hydrogen sulfide increases hepatic differentiation in tooth-pulp stem cells. Journal of Breath Research 2012; 6(1): 017103 doi: 10.1088/1752-7155/6/1/017103
|
| 5 |
Michael Trauner, Emina Halilbasic. Nuclear Receptors as New Perspective for the Management of Liver Diseases. Gastroenterology 2011; 140(4): 1120 doi: 10.1053/j.gastro.2011.02.044
|
| 6 |
Kemp M. Anderson, Christopher P. Gayer. The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity. Cells 2021; 10(11): 3206 doi: 10.3390/cells10113206
|
| 7 |
Stefano Fiorucci, Angela Zampella, Giuseppe Cirino, Mariarosaria Bucci, Eleonora Distrutti. Decoding the vasoregulatory activities of bile acid-activated receptors in systemic and portal circulation: role of gaseous mediators. American Journal of Physiology-Heart and Circulatory Physiology 2017; 312(1): H21 doi: 10.1152/ajpheart.00577.2016
|
| 8 |
Stefano Fiorucci, Cristina Di Giorgio, Eleonora Distrutti. Bile Acids and Their Receptors. Handbook of Experimental Pharmacology 2019; 256: 283 doi: 10.1007/164_2019_227
|
| 9 |
Wenjing Xu, Changting Cui, Chunmei Cui, Zhenzhen Chen, Haizeng Zhang, Qinghua Cui, Guoheng Xu, Jianglin Fan, Yu Han, Liangjie Tang, Giovanni Targher, Christopher D. Byrne, Ming‐Hua Zheng, Liming Yang, Jun Cai, Bin Geng. Hepatocellular cystathionine γ lyase/hydrogen sulfide attenuates nonalcoholic fatty liver disease by activating farnesoid X receptor. Hepatology 2022; 76(6): 1794 doi: 10.1002/hep.32577
|
| 10 |
Thuy T.P. Nguyen, Phuc L. Nguyen, So-Hyun Park, Chang Hwa Jung, Tae-Il Jeon. Hydrogen Sulfide and Liver Health: Insights into Liver Diseases. Antioxidants & Redox Signaling 2024; 40(1-3): 122 doi: 10.1089/ars.2023.0404
|
| 11 |
Stefano Fiorucci, Andrea Mencarelli, Sabrina Cipriani, Barbara Renga, Giuseppe Palladino, Luca Santucci, Eleonora Distrutti. Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice. British Journal of Pharmacology 2011; 164(8): 1929 doi: 10.1111/j.1476-5381.2011.01481.x
|
| 12 |
Tamara Merz, Josef A. Vogt, Ulrich Wachter, Enrico Calzia, Csaba Szabo, Rui Wang, Peter Radermacher, Oscar McCook. Impact of hyperglycemia on cystathionine-γ-lyase expression during resuscitated murine septic shock. Intensive Care Medicine Experimental 2017; 5(1) doi: 10.1186/s40635-017-0140-7
|
| 13 |
Hiroyuki Tsuchiya, Kerry-Ann da Costa, Sangmin Lee, Barbara Renga, Hartmut Jaeschke, Zhihong Yang, Stephen J. Orena, Michael J. Goedken, Yuxia Zhang, Bo Kong, Margitta Lebofsky, Swetha Rudraiah, Rana Smalling, Grace Guo, Stefano Fiorucci, Steven H. Zeisel, Li Wang. Interactions Between Nuclear Receptor SHP and FOXA1 Maintain Oscillatory Homocysteine Homeostasis in Mice. Gastroenterology 2015; 148(5): 1012 doi: 10.1053/j.gastro.2015.01.045
|
| 14 |
Barbara Renga, Daniela Francisci, Claudio D’Amore, Elisabetta Schiaroli, Adriana Carino, Franco Baldelli, Stefano Fiorucci. HIV-1 infection is associated with changes in nuclear receptor transcriptome, pro-inflammatory and lipid profile of monocytes. BMC Infectious Diseases 2012; 12(1) doi: 10.1186/1471-2334-12-274
|
| 15 |
Maja Ðanić, Bojan Stanimirov, Nebojša Pavlović, Svetlana Goločorbin-Kon, Hani Al-Salami, Karmen Stankov, Momir Mikov. Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01382
|
| 16 |
Arun J. Sanyal, Scott L. Friedman, Arthur J. McCullough, Lara Dimick‐Santos. Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: Findings and recommendations from an American Association for the Study of Liver Diseases–U.S. Food and Drug Administration Joint Workshop. Hepatology 2015; 61(4): 1392 doi: 10.1002/hep.27678
|
| 17 |
Shaoyu Mao, Xuemei Wang, Miaoqing Li, Hanshu Liu, Hongxia Liang. The role and mechanism of hydrogen sulfide in liver fibrosis. Nitric Oxide 2024; 145: 41 doi: 10.1016/j.niox.2024.02.002
|
| 18 |
Barbara Renga, Andrea Mencarelli, Claudio D'Amore, Sabrina Cipriani, Franco Baldelli, Angela Zampella, Eleonora Distrutti, Stefano Fiorucci. Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition. The FASEB Journal 2012; 26(7): 3021 doi: 10.1096/fj.11-195701
|
| 19 |
Kenneth R. Olson. The therapeutic potential of hydrogen sulfide: separating hype from hope. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2011; 301(2): R297 doi: 10.1152/ajpregu.00045.2011
|
| 20 |
Giuseppe Cirino, Csaba Szabo, Andreas Papapetropoulos. Physiological roles of hydrogen sulfide in mammalian cells, tissues, and organs. Physiological Reviews 2023; 103(1): 31 doi: 10.1152/physrev.00028.2021
|
| 21 |
Enrico M. Zardi, Antonio Abbate, Domenico Maria Zardi, Aldo Dobrina, Domenico Margiotta, Benjamin W. Van Tassel, Antonella Afeltra, Arun J. Sanyal. Cirrhotic Cardiomyopathy. Journal of the American College of Cardiology 2010; 56(7): 539 doi: 10.1016/j.jacc.2009.12.075
|
| 22 |
Juan I Sbodio, Solomon H Snyder, Bindu D Paul. Regulators of the transsulfuration pathway. British Journal of Pharmacology 2019; 176(4): 583 doi: 10.1111/bph.14446
|
| 23 |
Daniele M. Guizoni, Jean F. Vettorazzi, Everardo M. Carneiro, Ana Paula Davel. Modulation of endothelium-derived nitric oxide production and activity by taurine and taurine-conjugated bile acids. Nitric Oxide 2020; 94: 48 doi: 10.1016/j.niox.2019.10.008
|
| 24 |
Andrea Mencarelli, Stefano Fiorucci. FXR an emerging therapeutic target for the treatment of atherosclerosis. Journal of Cellular and Molecular Medicine 2010; 14(1-2): 79 doi: 10.1111/j.1582-4934.2009.00997.x
|
| 25 |
Revanth Kalluru, Sai Gadde, Rahul Chikatimalla, Thejaswi Dasaradhan, Jancy Koneti, Swathi priya Cherukuri. Cirrhotic Cardiomyopathy: The Interplay Between Liver and Heart. Cureus 2022; doi: 10.7759/cureus.27969
|
| 26 |
Philipp Schwabl, Eva Hambruch, Berit A. Seeland, Hubert Hayden, Michael Wagner, Lukas Garnys, Bastian Strobel, Tim-Lukas Schubert, Florian Riedl, Dieter Mitteregger, Michael Burnet, Patrick Starlinger, Georg Oberhuber, Ulrich Deuschle, Nataliya Rohr-Udilova, Bruno K. Podesser, Markus Peck-Radosavljevic, Thomas Reiberger, Claus Kremoser, Michael Trauner. The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction. Journal of Hepatology 2017; 66(4): 724 doi: 10.1016/j.jhep.2016.12.005
|
| 27 |
Katrin Panzitt, Gernot Zollner, Hanns-Ulrich Marschall, Martin Wagner. Recent advances on FXR-targeting therapeutics. Molecular and Cellular Endocrinology 2022; 552: 111678 doi: 10.1016/j.mce.2022.111678
|
| 28 |
María A. Pajares, Dolores Pérez-Sala. Mammalian Sulfur Amino Acid Metabolism: A Nexus Between Redox Regulation, Nutrition, Epigenetics, and Detoxification. Antioxidants & Redox Signaling 2018; 29(4): 408 doi: 10.1089/ars.2017.7237
|
| 29 |
Zhiqiang Lu, Yuanfu Lu, Xue Wang, Fangyu Wang, Youcai Zhang. Activation of intestinal GR–FXR and PPARα–UGT signaling exacerbates ibuprofen-induced enteropathy in mice. Archives of Toxicology 2018; 92(3): 1249 doi: 10.1007/s00204-017-2139-y
|
| 30 |
Kerstin Abshagen, Angela Kuhla, Berit Genz, Brigitte Vollmar. PanVascular Medicine. 2015; : 3607 doi: 10.1007/978-3-642-37078-6_142
|
| 31 |
Wenxuan Xu, Chunfeng Lu, Feng Zhang, Jiangjuan Shao, Shunyu Yao, Shizhong Zheng. Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor‐dependent inhibition of hepatic stellate cell contraction. The FEBS Journal 2017; 284(1): 114 doi: 10.1111/febs.13956
|
| 32 |
Barbara Renga, Mariarosaria Bucci, Sabrina Cipriani, Adriana Carino, Maria Chiara Monti, Angela Zampella, Antonella Gargiulo, Roberta d'Emmanuele di Villa Bianca, Eleonora Distrutti, Stefano Fiorucci. Cystathionine γ-lyase, a H2S-generating enzyme, is a GPBAR1-regulated gene and contributes to vasodilation caused by secondary bile acids. American Journal of Physiology-Heart and Circulatory Physiology 2015; 309(1): H114 doi: 10.1152/ajpheart.00087.2015
|
| 33 |
Mikkel Parsberg Werge, Adrian McCann, Elisabeth Douglas Galsgaard, Dorte Holst, Anne Bugge, Nicolai J. Wewer Albrechtsen, Lise Lotte Gluud. The Role of the Transsulfuration Pathway in Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine 2021; 10(5): 1081 doi: 10.3390/jcm10051081
|
| 34 |
Brennah Murphy, Resham Bhattacharya, Priyabrata Mukherjee. Hydrogen sulfide signaling in mitochondria and disease. The FASEB Journal 2019; 33(12): 13098 doi: 10.1096/fj.201901304R
|
| 35 |
Barbara Renga, Marco Migliorati, Andrea Mencarelli, Sabrina Cipriani, Claudio D'Amore, Eleonora Distrutti, Stefano Fiorucci. Farnesoid X receptor suppresses constitutive androstane receptor activity at the multidrug resistance protein-4 promoter. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 2011; 1809(3): 157 doi: 10.1016/j.bbagrm.2011.01.008
|
| 36 |
A. F. Perna, D. Ingrosso. Low hydrogen sulphide and chronic kidney disease: a dangerous liaison. Nephrology Dialysis Transplantation 2012; 27(2): 486 doi: 10.1093/ndt/gfr737
|
| 37 |
Gyorgy Baffy. Potential mechanisms linking gut microbiota and portal hypertension. Liver International 2019; 39(4): 598 doi: 10.1111/liv.13986
|
| 38 |
Jose Angel García-Merino, Beatriz de Lucas, Karen Herrera-Rocha, Diego Moreno-Pérez, Maria Gregoria Montalvo-Lominchar, Arantxa Fernández-Romero, Catalina Santiago, Margarita Pérez-Ruiz, Mar Larrosa. Flavanol-Rich Cocoa Supplementation Inhibits Mitochondrial Biogenesis Triggered by Exercise. Antioxidants 2022; 11(8): 1522 doi: 10.3390/antiox11081522
|
| 39 |
Michele Biagioli, Stefano Fiorucci. Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease. Liver Research 2021; 5(3): 119 doi: 10.1016/j.livres.2021.08.003
|
| 40 |
Gyorgy Baffy, Piero Portincasa. Gut Microbiota and Sinusoidal Vasoregulation in MASLD: A Portal Perspective. Metabolites 2024; 14(6): 324 doi: 10.3390/metabo14060324
|
| 41 |
Eva Hambruch, Olaf Kinzel, Claus Kremoser. On the Pharmacology of Farnesoid X Receptor Agonists: Give me an “A”, Like in “Acid”. Nuclear Receptor Research 2016; 3 doi: 10.11131/2016/101207
|
| 42 |
Philipp Schwabl, Wim Laleman. Novel treatment options for portal hypertension. Gastroenterology Report 2017; 5(2): 90 doi: 10.1093/gastro/gox011
|
| 43 |
Cong Zhao, Yu-ling Cong, Yi-jun Xu, Yan-ru Yin. Farnesoid X receptor in the study of fibrosis and its treatments. Chinese Medical Journal 2013; 126(19): 3775 doi: 10.3760/cma.j.issn.0366-6999.20130774
|
| 44 |
Elena Fauste, Silvia Rodrigo, Rodrigo Aguirre, Cristina Donis, Lourdes Rodríguez, Juan J. Álvarez‐Millán, María I. Panadero, Paola Otero, Carlos Bocos. Maternal Fructose Intake Increases Liver H2S Synthesis but Exarcebates its Fructose‐Induced Decrease in Female Progeny. Molecular Nutrition & Food Research 2020; 64(18) doi: 10.1002/mnfr.202000628
|
| 45 |
Simone Di Micco, Barbara Renga, Adriana Carino, Maria Valeria D’Auria, Angela Zampella, Raffaele Riccio, Stefano Fiorucci, Giuseppe Bifulco. Structural insights into Estrogen Related Receptor-β modulation: 4-Methylenesterols from Theonella swinhoei sponge as the first example of marine natural antagonists. Steroids 2014; 80: 51 doi: 10.1016/j.steroids.2013.11.017
|
| 46 |
Barbara Renga, Sabrina Cipriani, Adriana Carino, Michele Simonetti, Angela Zampella, Stefano Fiorucci, Matias A Avila. Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1. PLOS ONE 2015; 10(11): e0141082 doi: 10.1371/journal.pone.0141082
|
| 47 |
Guangdong Yang, Rui Wang. Chemistry, Biochemistry and Pharmacology of Hydrogen Sulfide. Handbook of Experimental Pharmacology 2015; 230: 85 doi: 10.1007/978-3-319-18144-8_4
|
| 48 |
Kerstin Abshagen, Angela Kuhla, Berit Genz, Brigitte Vollmar. PanVascular Medicine. 2014; : 1 doi: 10.1007/978-3-642-37393-0_142-1
|
| 49 |
Jason Schwartz, Andreas Rohrwasser, Elaine Hillas, Jenny Hatch, John Sorensen, Timothy Gayowski, William Hutson, Jean-Marc Lalouel. A Real-Time, Telemetric Method for Continuous Measurement of Portal Pressures. Journal of Surgical Research 2010; 159(2): 618 doi: 10.1016/j.jss.2009.10.026
|
| 50 |
Jorge A. López-Velázquez, Norberto C. Chávez-Tapia, Guadalupe Ponciano-Rodríguez, Vicente Sánchez-Valle, Stephen H. Caldwell, Misael Uribe, Nahum Méndez-Sánchez. Bilirubin alone as a biomarker for short-term mortality in acute-on-chronic liver failure: an important prognostic indicator. Annals of Hepatology 2014; 13(1): 98 doi: 10.1016/S1665-2681(19)30910-X
|
| 51 |
Eelke M Bos, Harry van Goor, Jaap A Joles, Matthew Whiteman, Henri G D Leuvenink. Hydrogen sulfide: physiological properties and therapeutic potential in ischaemia. British Journal of Pharmacology 2015; 172(6): 1479 doi: 10.1111/bph.12869
|
| 52 |
Adriana Carino, Michele Biagioli, Silvia Marchianò, Paolo Scarpelli, Angela Zampella, Vittorio Limongelli, Stefano Fiorucci. Disruption of TFGβ-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand. Pharmacological Research 2018; 131: 17 doi: 10.1016/j.phrs.2018.02.033
|
| 53 |
Stefano Fiorucci, Eleonora Distrutti. Targeting the transsulfuration-H 2 S pathway by FXR and GPBAR1 ligands in the treatment of portal hypertension. Pharmacological Research 2016; 111: 749 doi: 10.1016/j.phrs.2016.07.040
|